Click for best price
Recombinant Protein Drugs Market Size, Share 2022
This report contains market size and forecasts of Recombinant Protein Drugs in global, including the following market information:
Global Recombinant Protein Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Protein Drugs Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Recombinant Protein Drugs companies in 2021 (%)
The global Recombinant Protein Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Recombinant DNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Protein Drugs include Novo Nordisk, Amgen, Sanofi, Eli Lilly, Merck Serono, Ortho Biotech, Roche, Kyowa Hakko Kirin and Pharmingen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Protein Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Protein Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, by Type, 2021 (%)
Recombinant DNA
Recombinant RNA
Global Recombinant Protein Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical Industry
Others
Global Recombinant Protein Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Protein Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Protein Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Protein Drugs revenues share in global market, 2021 (%)
Key companies Recombinant Protein Drugs sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Recombinant Protein Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui
| Report Attributes |
Report Details |
| Report Title |
Recombinant Protein Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Protein Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Protein Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Protein Drugs Overall Market Size
2.1 Global Recombinant Protein Drugs Market Size: 2021 VS 2028
2.2 Global Recombinant Protein Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Protein Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Recombinant Protein Drugs Players in Global Market
3.2 Top Global Recombinant Protein Drugs Companies Ranked by Revenue
3.3 Global Recombinant Protein Drugs Revenue by Companies
3.4 Global Recombinant Protein Drugs Sales by Companies
3.5 Global Recombinant Protein Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Protein Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Protein Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Protein Drugs Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Protein Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Protein Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Protein Drugs Market Size Markets, 2021 & 2028
4.1.2 Recombinant DNA
4.1.3 Recombinant RNA
4.2 By Type - Global Recombinant Protein Drugs Revenue & Forecasts
4.2.1 By Type - Global Recombinant Protein Drugs Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Protein Drugs Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Protein Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Protein Drugs Sales & Forecasts
4.3.1 By Type - Global Recombinant Protein Drugs Sales, 2017-2022
4.3.2 By Type - Global Recombinant Protein Drugs Sales, 2023-2028
4.3.3 By Type - Global Recombinant Protein Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Protein Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Protein Drugs Market Size, 2021 & 2028
5.1.2 Pharmaceutical Industry
5.1.3 Others
5.2 By Application - Global Recombinant Protein Drugs Revenue & Forecasts
5.2.1 By Application - Global Recombinant Protein Drugs Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Protein Drugs Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Protein Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Protein Drugs Sales & Forecasts
5.3.1 By Application - Global Recombinant Protein Drugs Sales, 2017-2022
5.3.2 By Application - Global Recombinant Protein Drugs Sales, 2023-2028
5.3.3 By Application - Global Recombinant Protein Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Protein Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Recombinant Protein Drugs Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Protein Drugs Revenue & Forecasts
6.2.1 By Region - Global Recombinant Protein Drugs Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Protein Drugs Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Protein Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Protein Drugs Sales & Forecasts
6.3.1 By Region - Global Recombinant Protein Drugs Sales, 2017-2022
6.3.2 By Region - Global Recombinant Protein Drugs Sales, 2023-2028
6.3.3 By Region - Global Recombinant Protein Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Protein Drugs Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Protein Drugs Sales, 2017-2028
6.4.3 US Recombinant Protein Drugs Market Size, 2017-2028
6.4.4 Canada Recombinant Protein Drugs Market Size, 2017-2028
6.4.5 Mexico Recombinant Protein Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Protein Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Protein Drugs Sales, 2017-2028
6.5.3 Germany Recombinant Protein Drugs Market Size, 2017-2028
6.5.4 France Recombinant Protein Drugs Market Size, 2017-2028
6.5.5 U.K. Recombinant Protein Drugs Market Size, 2017-2028
6.5.6 Italy Recombinant Protein Drugs Market Size, 2017-2028
6.5.7 Russia Recombinant Protein Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Protein Drugs Market Size, 2017-2028
6.5.9 Benelux Recombinant Protein Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Protein Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Protein Drugs Sales, 2017-2028
6.6.3 China Recombinant Protein Drugs Market Size, 2017-2028
6.6.4 Japan Recombinant Protein Drugs Market Size, 2017-2028
6.6.5 South Korea Recombinant Protein Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Protein Drugs Market Size, 2017-2028
6.6.7 India Recombinant Protein Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Protein Drugs Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Protein Drugs Sales, 2017-2028
6.7.3 Brazil Recombinant Protein Drugs Market Size, 2017-2028
6.7.4 Argentina Recombinant Protein Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Protein Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Protein Drugs Sales, 2017-2028
6.8.3 Turkey Recombinant Protein Drugs Market Size, 2017-2028
6.8.4 Israel Recombinant Protein Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Protein Drugs Market Size, 2017-2028
6.8.6 UAE Recombinant Protein Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Recombinant Protein Drugs Major Product Offerings
7.1.4 Novo Nordisk Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Novo Nordisk Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Recombinant Protein Drugs Major Product Offerings
7.2.4 Amgen Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Recombinant Protein Drugs Major Product Offerings
7.3.4 Sanofi Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Recombinant Protein Drugs Major Product Offerings
7.4.4 Eli Lilly Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Eli Lilly Key News
7.5 Merck Serono
7.5.1 Merck Serono Corporate Summary
7.5.2 Merck Serono Business Overview
7.5.3 Merck Serono Recombinant Protein Drugs Major Product Offerings
7.5.4 Merck Serono Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Merck Serono Key News
7.6 Ortho Biotech
7.6.1 Ortho Biotech Corporate Summary
7.6.2 Ortho Biotech Business Overview
7.6.3 Ortho Biotech Recombinant Protein Drugs Major Product Offerings
7.6.4 Ortho Biotech Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Ortho Biotech Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche Recombinant Protein Drugs Major Product Offerings
7.7.4 Roche Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Roche Key News
7.8 Kyowa Hakko Kirin
7.8.1 Kyowa Hakko Kirin Corporate Summary
7.8.2 Kyowa Hakko Kirin Business Overview
7.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Major Product Offerings
7.8.4 Kyowa Hakko Kirin Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Kyowa Hakko Kirin Key News
7.9 Pharmingen
7.9.1 Pharmingen Corporate Summary
7.9.2 Pharmingen Business Overview
7.9.3 Pharmingen Recombinant Protein Drugs Major Product Offerings
7.9.4 Pharmingen Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Pharmingen Key News
7.10 Abcam
7.10.1 Abcam Corporate Summary
7.10.2 Abcam Business Overview
7.10.3 Abcam Recombinant Protein Drugs Major Product Offerings
7.10.4 Abcam Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Abcam Key News
7.11 GenSci
7.11.1 GenSci Corporate Summary
7.11.2 GenSci Recombinant Protein Drugs Business Overview
7.11.3 GenSci Recombinant Protein Drugs Major Product Offerings
7.11.4 GenSci Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.11.5 GenSci Key News
7.12 SL PHARM
7.12.1 SL PHARM Corporate Summary
7.12.2 SL PHARM Recombinant Protein Drugs Business Overview
7.12.3 SL PHARM Recombinant Protein Drugs Major Product Offerings
7.12.4 SL PHARM Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.12.5 SL PHARM Key News
7.13 Dongbao Pharm
7.13.1 Dongbao Pharm Corporate Summary
7.13.2 Dongbao Pharm Recombinant Protein Drugs Business Overview
7.13.3 Dongbao Pharm Recombinant Protein Drugs Major Product Offerings
7.13.4 Dongbao Pharm Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Dongbao Pharm Key News
7.14 Ankebio
7.14.1 Ankebio Corporate Summary
7.14.2 Ankebio Business Overview
7.14.3 Ankebio Recombinant Protein Drugs Major Product Offerings
7.14.4 Ankebio Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Ankebio Key News
7.15 NCPC
7.15.1 NCPC Corporate Summary
7.15.2 NCPC Business Overview
7.15.3 NCPC Recombinant Protein Drugs Major Product Offerings
7.15.4 NCPC Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.15.5 NCPC Key News
7.16 Heng Rui
7.16.1 Heng Rui Corporate Summary
7.16.2 Heng Rui Business Overview
7.16.3 Heng Rui Recombinant Protein Drugs Major Product Offerings
7.16.4 Heng Rui Recombinant Protein Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Heng Rui Key News
8 Global Recombinant Protein Drugs Production Capacity, Analysis
8.1 Global Recombinant Protein Drugs Production Capacity, 2017-2028
8.2 Recombinant Protein Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Protein Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Protein Drugs Supply Chain Analysis
10.1 Recombinant Protein Drugs Industry Value Chain
10.2 Recombinant Protein Drugs Upstream Market
10.3 Recombinant Protein Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Protein Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Protein Drugs in Global Market
Table 2. Top Recombinant Protein Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Protein Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Protein Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Protein Drugs Sales by Companies, (K Doses), 2017-2022
Table 6. Global Recombinant Protein Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Protein Drugs Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Recombinant Protein Drugs Product Type
Table 9. List of Global Tier 1 Recombinant Protein Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Recombinant Protein Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Protein Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Protein Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Protein Drugs Sales (K Doses), 2017-2022
Table 15. By Type - Global Recombinant Protein Drugs Sales (K Doses), 2023-2028
Table 16. By Application ? Global Recombinant Protein Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Protein Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Protein Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Protein Drugs Sales (K Doses), 2017-2022
Table 20. By Application - Global Recombinant Protein Drugs Sales (K Doses), 2023-2028
Table 21. By Region ? Global Recombinant Protein Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Protein Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Protein Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Protein Drugs Sales (K Doses), 2017-2022
Table 25. By Region - Global Recombinant Protein Drugs Sales (K Doses), 2023-2028
Table 26. By Country - North America Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Protein Drugs Sales, (K Doses), 2017-2022
Table 29. By Country - North America Recombinant Protein Drugs Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Protein Drugs Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Recombinant Protein Drugs Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Protein Drugs Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Recombinant Protein Drugs Sales, (K Doses), 2023-2028
Table 38. By Country - South America Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Protein Drugs Sales, (K Doses), 2017-2022
Table 41. By Country - South America Recombinant Protein Drugs Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Protein Drugs Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Protein Drugs Sales, (K Doses), 2023-2028
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Recombinant Protein Drugs Product Offerings
Table 48. Novo Nordisk Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Recombinant Protein Drugs Product Offerings
Table 51. Amgen Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Recombinant Protein Drugs Product Offerings
Table 54. Sanofi Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Eli Lilly Corporate Summary
Table 56. Eli Lilly Recombinant Protein Drugs Product Offerings
Table 57. Eli Lilly Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Merck Serono Corporate Summary
Table 59. Merck Serono Recombinant Protein Drugs Product Offerings
Table 60. Merck Serono Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Ortho Biotech Corporate Summary
Table 62. Ortho Biotech Recombinant Protein Drugs Product Offerings
Table 63. Ortho Biotech Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Roche Corporate Summary
Table 65. Roche Recombinant Protein Drugs Product Offerings
Table 66. Roche Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Kyowa Hakko Kirin Corporate Summary
Table 68. Kyowa Hakko Kirin Recombinant Protein Drugs Product Offerings
Table 69. Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. Pharmingen Corporate Summary
Table 71. Pharmingen Recombinant Protein Drugs Product Offerings
Table 72. Pharmingen Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Abcam Corporate Summary
Table 74. Abcam Recombinant Protein Drugs Product Offerings
Table 75. Abcam Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. GenSci Corporate Summary
Table 77. GenSci Recombinant Protein Drugs Product Offerings
Table 78. GenSci Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. SL PHARM Corporate Summary
Table 80. SL PHARM Recombinant Protein Drugs Product Offerings
Table 81. SL PHARM Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 82. Dongbao Pharm Corporate Summary
Table 83. Dongbao Pharm Recombinant Protein Drugs Product Offerings
Table 84. Dongbao Pharm Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 85. Ankebio Corporate Summary
Table 86. Ankebio Recombinant Protein Drugs Product Offerings
Table 87. Ankebio Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 88. NCPC Corporate Summary
Table 89. NCPC Recombinant Protein Drugs Product Offerings
Table 90. NCPC Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 91. Heng Rui Corporate Summary
Table 92. Heng Rui Recombinant Protein Drugs Product Offerings
Table 93. Heng Rui Recombinant Protein Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 94. Recombinant Protein Drugs Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 95. Global Recombinant Protein Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 96. Global Recombinant Protein Drugs Production by Region, 2017-2022 (K Doses)
Table 97. Global Recombinant Protein Drugs Production by Region, 2023-2028 (K Doses)
Table 98. Recombinant Protein Drugs Market Opportunities & Trends in Global Market
Table 99. Recombinant Protein Drugs Market Drivers in Global Market
Table 100. Recombinant Protein Drugs Market Restraints in Global Market
Table 101. Recombinant Protein Drugs Raw Materials
Table 102. Recombinant Protein Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Recombinant Protein Drugs Downstream
Table 104. Recombinant Protein Drugs Downstream Clients in Global Market
Table 105. Recombinant Protein Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Protein Drugs Segment by Type
Figure 2. Recombinant Protein Drugs Segment by Application
Figure 3. Global Recombinant Protein Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Protein Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Protein Drugs Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Protein Drugs Revenue in 2021
Figure 9. By Type - Global Recombinant Protein Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Protein Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Protein Drugs Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Recombinant Protein Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Protein Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Protein Drugs Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Recombinant Protein Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Protein Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Protein Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Protein Drugs Sales Market Share, 2017-2028
Figure 19. US Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Protein Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Protein Drugs Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Protein Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Protein Drugs Sales Market Share, 2017-2028
Figure 33. China Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Protein Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Protein Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Protein Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Protein Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Protein Drugs Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Recombinant Protein Drugs by Region, 2021 VS 2028
Figure 50. Recombinant Protein Drugs Industry Value Chain
Figure 51. Marketing Channels
